The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson's Disease

25Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

O-Glycosylation changes in misfolded proteins are of particular interest in understanding neurodegenerative conditions such as Parkinson's disease (PD) and incidental Lewy body disease (ILBD). This work outlines optimizations of a microwave-assisted nonreductive release to limit glycan degradation and employs this methodology to analyze O-glycosylation on the human striatum and substantia nigra tissue in PD, ILBD, and healthy controls, working alongside well-established reductive release approaches. A total of 70 O-glycans were identified, with ILBD presenting significantly decreased levels of mannose-core (p = 0.017) and glucuronylated structures (p = 0.039) in the striatum and PD presenting an increase in sialylation (p < 0.001) and a decrease in sulfation (p = 0.001). Significant increases in sialylation (p = 0.038) in PD were also observed in the substantia nigra. This is the first study to profile the whole nigrostriatal O-glycome in healthy, PD, and ILBD tissues, outlining disease biomarkers alongside benefits of employing orthogonal techniques for O-glycan analysis.

Cite

CITATION STYLE

APA

Wilkinson, H., Thomsson, K. A., Rebelo, A. L., Hilliard, M., Pandit, A., Rudd, P. M., … Saldova, R. (2021). The O-Glycome of Human Nigrostriatal Tissue and Its Alteration in Parkinson’s Disease. Journal of Proteome Research, 20(8), 3913–3924. https://doi.org/10.1021/acs.jproteome.1c00219

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free